Evidence map›Paper›PMID 38538606›Full record

ArticleScientific reports2024

New role of fat-free mass in cancer risk linked with genetic predisposition.

Benjamin H L Harris, Matteo Di Giovannantonio, Ping Zhang, David A Harris, Simon R Lord, Naomi E Allen, Tim S Maughan, Richard J Bryant, Adrian L Harris, Gareth L Bond and 1 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
4.9field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it, 16 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 2 countries.

Benjamin H L Harris *Department of Oncology, University of Oxford, Oxford, UK. benjamin.harris@oncology.ox.ac.uk.
Matteo Di Giovannantonio *Department of Oncology, University of Oxford, Oxford, UK.
Ping ZhangWellcome Trust Centre for Human Genetics, University of Oxford, Oxford, UK.
David A HarrisSt Anne's College, University of Oxford, 56 Woodstock Rd, Oxford, UK.
Simon R LordDepartment of Oncology, University of Oxford, Oxford, UK.
Naomi E AllenClinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.
Tim S MaughanDepartment of Oncology, University of Oxford, Oxford, UK.
Richard J BryantNuffield Department of Surgical Sciences, University of Oxford, Oxford, UK.
Adrian L HarrisDepartment of Oncology, University of Oxford, Oxford, UK.
Gareth L BondInstitute of Cancer & Genomics Sciences, University of Birmingham, Bimingham, UK.
Francesca M BuffaDepartment of Oncology, University of Oxford, Oxford, UK. francesca.buffa@oncology.ox.ac.uk.
University of Oxford · GBBocconi University · ITCentre for Human Genetics · GBChurchill Hospital · GBGenomics (United Kingdom) · GB

Funding

Cancer Research UK 22748European Research Council 772970
6 · The paper itself

Abstract

Cancer risk is associated with the widely debated measure body mass index (BMI). Fat mass and fat-free mass measurements from bioelectrical impedance may further clarify this association. The UK Biobank is a rare resource in which bioelectrical impedance and BMI data was collected on ~ 500,000 individuals. Using this dataset, a comprehensive analysis using regression, principal component and genome-wide genetic association, provided multiple levels of evidence that increasing whole body fat (WBFM) and fat-free mass (WBFFM) are both associated with increased post-menopausal breast cancer risk, and colorectal cancer risk in men. WBFM was inversely associated with prostate cancer. We also identified rs615029[T] and rs1485995[G] as associated in independent analyses with both PMBC (p = 1.56E-17 and 1.78E-11) and WBFFM (p = 2.88E-08 and 8.24E-12), highlighting splice variants of the intriguing long non-coding RNA CUPID1 (LINC01488) as a potential link between PMBC risk and fat-free mass.

Indexed as

Body CompositionNeoplasmsBody Mass IndexElectric ImpedanceGenetic Predisposition to DiseaseHumansMale

Identifiers

PMID38538606
PMCPMC10973462
OpenAlexW4393233791

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.